These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18670732)

  • 1. The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Clin Exp Nephrol; 2009 Apr; 13(2):101-106. PubMed ID: 18670732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of correction of anaemia in patients with congestive heart failure: a short review.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Eur J Heart Fail; 2008 Sep; 10(9):819-23. PubMed ID: 18703380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists.
    Silverberg DS; Wexler D; Iaina A; Steinbruch S; Wollman Y; Schwartz D
    Int Urol Nephrol; 2006; 38(2):295-310. PubMed ID: 16868702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.
    Iaina A; Silverberg DS; Wexler D
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):95-100. PubMed ID: 16265380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?
    Silverberg DS; Wexler D; Iaina A
    J Nephrol; 2004; 17(6):749-61. PubMed ID: 15593047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome.
    Silverberg DS
    Heart Fail Rev; 2011 Nov; 16(6):609-14. PubMed ID: 20865450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.
    Silverberg DS; Wexler D; Blum M; Keren G; Sheps D; Leibovitch E; Brosh D; Laniado S; Schwartz D; Yachnin T; Shapira I; Gavish D; Baruch R; Koifman B; Kaplan C; Steinbruch S; Iaina A
    J Am Coll Cardiol; 2000 Jun; 35(7):1737-44. PubMed ID: 10841219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anemia of heart failure.
    Silverberg DS; Wexler D; Palazzuoli A; Iaina A; Schwartz D
    Acta Haematol; 2009; 122(2-3):109-19. PubMed ID: 19907148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
    Palazzuoli A; Silverberg DS; Calabrò A; Spinelli T; Quatrini I; Campagna MS; Franci B; Nuti R
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.
    Silverberg DS; Wexler D; Sheps D; Blum M; Keren G; Baruch R; Schwartz D; Yachnin T; Steinbruch S; Shapira I; Laniado S; Iaina A
    J Am Coll Cardiol; 2001 Jun; 37(7):1775-80. PubMed ID: 11401110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia in chronic kidney disease and congestive heart failure.
    Silverberg DS; Wexler D; Blum B; Iaina A
    Blood Purif; 2003; 21(1):124-30. PubMed ID: 12596758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron.
    Silverberg DS; Wexler D; Blum M; Tchebiner JZ; Sheps D; Keren G; Schwartz D; Baruch R; Yachnin T; Shaked M; Schwartz I; Steinbruch S; Iaina A
    Nephrol Dial Transplant; 2003 Jan; 18(1):141-6. PubMed ID: 12480972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotropic effects.
    Manolis AS; Tzeis S; Triantafyllou K; Michaelidis J; Pyrros I; Sakellaris N; Kranidis A; Melita H
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Oct; 5(5):355-75. PubMed ID: 16248829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia in chronic congestive heart failure: frequency, prognosis, and treatment.
    Crosato M; Steinborn W; Anker SD
    Heart Fail Monit; 2003; 4(1):2-6. PubMed ID: 12808478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin should be part of congestive heart failure management.
    Silverberg DS; Wexler D; Blum M; Schwartz D; Wollman Y; Iaina A
    Kidney Int Suppl; 2003 Nov; (87):S40-7. PubMed ID: 14531772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Kourea K; Panou F; Farmakis D; Paraskevaidis I; Ikonomidis I; Filippatos G; Kremastinos DT
    Am Heart J; 2008 Apr; 155(4):751.e1-7. PubMed ID: 18371487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations.
    Silverberg DS; Wexler D; Blum M; Iaina A
    Clin Nephrol; 2003 Jul; 60 Suppl 1():S93-102. PubMed ID: 12940539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.